Advertisement

Topics

SELEXIS Company Profile

18:02 EDT 21st June 2018 | BioPortfolio

July 2005Opening of the new R&D facility in Plan-les-OuatesSelexis is a private, Swiss-based biotechnology company leading the development of innovative solutions using proprietary technologies and expression systems for the rapid production of proteins for R&D and therapeutic applications. Industry experts are looking for novel and innovative solutions to increase the yields of recombinant proteins and to rapidly advance products into production for clinical phases.Referred to as MARtech, Matrix Attachment Region technologies provide powerful and flexible integrated solutions for cellular protein production. Selexis’ MARtech offers a number of significant advantages over traditional approaches including:- Acceleration of drug discovery by reducing the development time up to 8 months. Knowing that a delay of a single day can cost a pharmaceutical company between US$1 million and US$13 million in lost sales, this is a huge benefit.

Location

655, Montgomery St. STE 540
San Francisco
California
94111
United States of America

Contact

Phone: 1 415 273 51 41
Fax: 1 415 837 32 04
Email: info@selexis.com


News Articles [20 Associated News Articles listed on BioPortfolio]

Xencor, Selexis Ink CLAs to Advance XmAb Bispecific ADCs

Expanded partnership leverages Selexis’ recombinant therapeutic development solutions

Xencor extends ‘plug-and-play’ deal with Selexis, signs four mAbs

Xencor and Selexis will extend their strategic partnership with the signing of four commercial license agreements to advance XmAb bispecific antibody drug candidates.

Compugen Licenses Selexis SUREtechnology Platform

Will leverage Selexis’ mammalian cell line-based protein expression platform to develop antibody-based therapeutics

Compugen licenses Selexis cell line tech

Compugen has selected Selexisâ SUREtechnology cell expression platform to generate high-performance research cell banks (RCBs) and support its antibody pipeline.

Selexis says $2m investment will speed up cell bank delivery time

Cell line developer Selexis has invested in laboratory equipment to reduce delivery times of its high expressing and stable research cell banks.

Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the ...

Selexis SUREtechnology Platform™ in use for the generation of high-performance research cell banks for Compugen Read more...

Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of Antibody-Based Therapeutics

Selexis SUREtechnology Platform™ in use for the generation of high-performance research cell banks for Compugen Selexis SA, a pioneering life sciences company and a g...

Selexis SA to Participate at Several Upcoming Industry Conferences

Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today its planned participation at upcoming indus...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Selexis SA

Selexis is a privately held Swiss biotechnology company dedicated to the development of innovative technologies and expert services that enable significant improvements in the time, effort, and costs ...

Selexis SA and TeneoBio, Inc.

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

Selexis SA and Pelican Therapeutics

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

Selexis SA and Turgut Pharmaceuticals

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

Selexis SA and International AIDS Vaccine Initiative (IAVI)

More Information about "SELEXIS" on BioPortfolio

We have published hundreds of SELEXIS news stories on BioPortfolio along with dozens of SELEXIS Clinical Trials and PubMed Articles about SELEXIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SELEXIS Companies in our database. You can also find out about relevant SELEXIS Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record